Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stephen P. Lockhart"'
Autor:
Louise Murdoch, Karen Quan, James A. Baber, Agnes W. Y. Ho, Ying Zhang, Xia Xu, Claire Lu, David Cooper, Kenneth Koury, Stephen P. Lockhart, Annaliesa S. Anderson, Özlem Türeci, Uğur Şahin, Kena A. Swanson, William C. Gruber, Nicholas Kitchin, the C4591030 Clinical Trial Group
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 9, Pp 2241-2258 (2023)
Abstract Introduction Vaccination is a critical tool for preventing coronavirus disease 2019 (COVID-19) and influenza illnesses. Coadministration of the COVID-19 vaccine, BNT162b2, with seasonal inactivated influenza vaccine (SIIV) can provide substa
Externí odkaz:
https://doaj.org/article/c10e41db0b574d23af185c6952e55029
Autor:
Alice Pressman, Stephen H Lockhart, Joseph Wilcox, Kelly Smits, Joan Etzell, Sami Albeiroti, Michele DeRee, Christine Flaherty, Sheila Genolaga, Michelle Goodreau, Farah Refai, Alexandra Restall, Katarina Lanner-Cusin, Kristen MJ Azar
Publikováno v:
Women's Health, Vol 17 (2021)
Objective: COVID-19 and associated morbidity and mortality has disproportionately affected minoritized populations. The epidemiology of spread of COVID-19 among pregnant women by race/ethnicity is not well described. Using data from a large healthcar
Externí odkaz:
https://doaj.org/article/753995f1e86b4fa8a00bf2823cc41daf
Autor:
Stephen J. Thomas, John L. Perez, Stephen P. Lockhart, Subramanian Hariharan, Nicholas Kitchin, Ruth Bailey, Katherine Liau, Eleni Lagkadinou, Özlem Türeci, Ugur Şahin, Xia Xu, Kenneth Koury, Samuel S. Dychter, Claire Lu, Teresa C. Gentile, William C. Gruber
Publikováno v:
Vaccine
Introduction Individuals with an underlying malignancy have high risk of poor COVID-19 outcomes. In clinical trials, COVID-19 vaccines were safe and efficacious against infection, hospitalization, and death, but most trials excluded participants with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cb5f1adc9988d2825bb0d5a9ad1defc
https://doi.org/10.1016/j.vaccine.2021.12.046
https://doi.org/10.1016/j.vaccine.2021.12.046
Autor:
Emilio A. Emini, A. Krishna Prasad, Stephen P. Lockhart, Daniel A. Scott, Kathrin U. Jansen, Annaliesa S. Anderson, William C. Gruber, Jeremy A. Duke, Fikri Y. Avci, Jin-hwan Kim, Jianxin Gu, Kent Murphy, Stephen A. Kolodziej, Francesco Berti, Michelle M. Kuttel, Neil Ravenscroft, A. R. Vartak, S. J. Sucheck, Lakshmi Khandke, Jo Anne Welsch, Mark R. Alderson, Ingrid L. Scully, Kena A. Swanson, Isis Kanevsky, Mario A. Monteiro, Alexander Noll, Renee M. Laird, Brittany Pequegnat, Zuchao Ma, Lisa Bertolo, Christina DePass, Eman Omari, Pawel Gabryelski, Olena Redkyna, Yuening Jiao, Silvia Borrelli, Frederic Poly, Patricia Guerry, Christopher Jones, John P. Hennessey, Paolo Costantino, Philippe Talaga, Michel Beurret, Earl Zablackis, Carl Frasch
Publikováno v:
Expert Review of Vaccines. 5:553-564
Since 2000, when the first pneumococcal conjugate vaccine was introduced into routine use in the USA, it has had a substantial impact on invasive pneumococcal disease both in the immunized and nonimmunized population. It has also been shown to reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ad05fb592c3c7c046c28756e1d6301b
https://doi.org/10.1586/14760584.5.4.553
https://doi.org/10.1586/14760584.5.4.553
Autor:
P. S. Warrington, S. G. Allan, Stephen P Lockhart, John F. Smyth, M. A. Cornbleet, Robert C. F. Leonard
Publikováno v:
European Journal of Cancer and Clinical Oncology. 20:1481-1484
A randomised, double-blind prospective trial was conducted to determine the relative anti-emetic efficacy of three dose levels of metoclopramide in cancer patients receiving combination chemotherapy including cis-platinum. With consecutive courses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52f939462429c03d691b724f06146e19
https://doi.org/10.1016/0277-5379(84)90140-8
https://doi.org/10.1016/0277-5379(84)90140-8